Cartesian Therapeutics (RNAC) Long-Term Debt Issuances (2020)
Cartesian Therapeutics (RNAC) reported Long-Term Debt Issuances of -$102000.0 for Q4 2020.
Cartesian Therapeutics (RNAC) Long-Term Debt Issuances (2020) Analysis & Trends
Cartesian Therapeutics (RNAC) has 1 years of Long-Term Debt Issuances data on file, last reported at -$102000.0 in Q4 2020.
- Long-Term Debt Issuances for Q4 2020 came in at -$102000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2021 was -$102000.0 (changed 0.0% YoY), and the FY2020 annual result was $24.7 million, changed N/A from the prior year.
- Long-Term Debt Issuances steadied at -$102000.0 in Q4 2020 per RNAC's latest filing.
- Over five years, Long-Term Debt Issuances peaked at -$102000.0 in Q4 2020 and troughed at -$102000.0 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.73 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Cartesian Therapeutics | 261.84 Mn | 261.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -102,000.00 |
| Dec 31, 2020 | -102,000.00 |